Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
allergan
anemia
bristol-myers squibb
celgene
clinical trials
eli lilly
gene therapy
gilead sciences
glaxosmithkline
graybug vision
What
days
3
×
bio
roundup
abbvie’s
ahead
airport
annual
apocalypse
august
beds
biofourmis
biotech
bucks
busy
cancer
celebrate
celgene
chance
corner
day
decisions
devices
drugs
fallout
fda
forward
gone
holiday
home
j.p
jpm
labor
legacy
looking
news
nods
notes
opioid
past
people
Language
unset
Current search:
novartis
×
days
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
